Global Retirement Partners LLC Lowers Position in Sanofi (NASDAQ:SNY)

Global Retirement Partners LLC trimmed its position in shares of Sanofi (NASDAQ:SNY) by 4.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 6,028 shares of the company’s stock after selling 287 shares during the quarter. Global Retirement Partners LLC’s holdings in Sanofi were worth $291,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in the company. Hara Capital LLC boosted its stake in shares of Sanofi by 16.2% in the 4th quarter. Hara Capital LLC now owns 4,888 shares of the company’s stock worth $236,000 after buying an additional 680 shares during the last quarter. Cardinal Capital Management boosted its position in Sanofi by 1.9% in the fourth quarter. Cardinal Capital Management now owns 68,805 shares of the company’s stock worth $3,318,000 after purchasing an additional 1,282 shares during the last quarter. Kestra Investment Management LLC bought a new position in Sanofi in the 4th quarter valued at $84,000. Sierra Ocean LLC purchased a new stake in shares of Sanofi during the 4th quarter valued at $44,000. Finally, Keystone Financial Services raised its stake in shares of Sanofi by 2.0% during the 4th quarter. Keystone Financial Services now owns 13,883 shares of the company’s stock worth $670,000 after purchasing an additional 278 shares during the period. Institutional investors own 14.04% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the stock. StockNews.com downgraded shares of Sanofi from a “buy” rating to a “hold” rating in a report on Thursday, December 12th. Deutsche Bank Aktiengesellschaft upgraded shares of Sanofi from a “sell” rating to a “hold” rating in a research note on Thursday, January 30th. Finally, Sanford C. Bernstein upgraded Sanofi to a “strong-buy” rating in a research note on Thursday, January 30th. Two research analysts have rated the stock with a hold rating, one has issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $60.00.

Sanofi Trading Down 1.3 %

Shares of SNY opened at $53.75 on Tuesday. Sanofi has a fifty-two week low of $45.22 and a fifty-two week high of $58.97. The business has a 50-day moving average of $51.10 and a 200 day moving average of $52.55. The firm has a market cap of $136.41 billion, a P/E ratio of 21.59, a price-to-earnings-growth ratio of 1.01 and a beta of 0.57. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.14 and a current ratio of 1.46.

Sanofi (NASDAQ:SNY) last posted its earnings results on Thursday, January 30th. The company reported $0.70 earnings per share for the quarter, hitting the consensus estimate of $0.70. Sanofi had a net margin of 12.77% and a return on equity of 25.61%. As a group, research analysts forecast that Sanofi will post 4.36 EPS for the current year.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.